Clinical Trial

Assessing a Clinically-meaningful Opioid Withdrawal Phenotype

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Evaluate individual differences in the expression of opioid withdrawal symptoms in persons with opioid use disorder (OUD) while completing a clinically-indicated medication taper.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2021-08-24; most recent amendment 2025-09-05.
Status change: Not Yet Recruiting → Recruiting 2021-10-21
Trial Details
NCT Number NCT05027919
Lead Sponsor University of Maryland, Baltimore
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Opioid Withdrawal, Opioid Use Disorder, Opioid Craving
Enrollment 60 participants
Start Date 2021-12-01
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-09-12